Letrasan 2.5 mg
Letrasan 2.5 mg An aromatase inhibitor containing Letrozole for hormone-positive breast cancer in postmenopausal women. Used as initial treatment, after tamoxifen therapy, or for advanced disease management.
Letrasan 2.5 mg
Product Name: Letrasan 2.5 mg
Generic Name: Letrozole
Indications
- Adjuvant Treatment of Early Breast Cancer: for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer.
- Extended Adjuvant Treatment: for extended adjuvant treatment of early breast cancer in postmenopausal women who have completed five years of tamoxifen therapy.
- Advanced or Metastatic Breast Cancer: as first-line treatment for postmenopausal women with hormone receptor-positive or unknown advanced breast cancer, or for treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Strength: 2.5 mg
Pack Size: Blister pack
Dosage Form: Film-coated tablet
Categories: Pharmaceuticals
Therapeutic Class: Antineoplastic Agent (Aromatase Inhibitor)